Prédire la survenue d'un diabète: la place de scores cliniques et/ou génétiques [Genetic and/or clinical scores to anticipate the onset of diabetes]


Autoria(s): Waeber Gérard; Mooser V.; Vollenweider Peter
Data(s)

2009

Resumo

Diabetes represents an important health burden on our society: for example in Lausanne (Switzerland) 16% of the adult population have abnormal glucose homeostasis and 6% have diabetes, of which about a third is not aware. Some guidelines identify the "at risk" population for which screening seems indicated. Simple clinical scores have been developed at allow to better estimate the risk of diabetes and hence to potentially better target screening of the disease. The recent discovery of more that 18 genetic variants associated with an increased risk to develop the diseased has allowed to include individual genotype into genetic risk scores. We will discuss in this article the usefulness of these genetic score, how they compare to clinical score, their implication for clinical practice as well as their potential ethical or economical consequences.

Identificador

http://serval.unil.ch/?id=serval:BIB_F9D3FEF47C1A

isbn:1660-9379

pmid:19968025

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 5, no. 223, pp. 2136-2138, 2140-2141

Tipo

info:eu-repo/semantics/article

article